ConductScience.org, home

Paper · 8970988

RNase H domain of Moloney murine leukemia virus reverse transcriptase retains activity but requires the polymerase domain for specificity.

Schultz SJ and 1 other. J Virol, 1996. Cited by 27 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. RNase H domain of Moloney murine leukemia virus reverse transcriptase retains activity but requires the polymerase domain for specificity. Papers, record 8970988. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8970988

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
RNase H domain of Moloney murine leukemia virus reverse transcriptase retains activity but requires the polymerase domain for specificity.
PubMed
Journal
J Virol
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
0.62
iCite
Revised in PubMed
2020-07-24
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schultz SJS J
2Champoux JJJ J

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA-Directed DNA PolymeraseMajor topic
Moloney murine leukemia virusMajor topic
RNA-Directed DNA PolymeraseMajor topic
Retroviridae ProteinsMajor topic
Ribonuclease HMajor topic
Glutathione Transferase
RNA
RNA, Transfer

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R37 CA51605NCI NIH HHSUnited StatesR37CA051605PubMed and NIH

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12,477,553Plus-strand priming by Moloney murine leukemia virus. The sequence features important for cleavage by RNase H.J Mol Biol1989https://conductscience.org/library/papers/2477553PubMed
22,466,838Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching.J Biol Chem1989https://conductscience.org/library/papers/2466838PubMed
31,688,626Specificities involved in the initiation of retroviral plus-strand DNA.J Virol1990https://conductscience.org/library/papers/1688626PubMed
41,691,093HIV-1 RT-associated ribonuclease H displays both endonuclease and 3'----5' exonuclease activity.EMBO J1990https://conductscience.org/library/papers/1691093PubMed
51,691,564Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase.Virology1990https://conductscience.org/library/papers/1691564PubMed
61,693,920Processing of the primer for plus strand DNA synthesis by human immunodeficiency virus 1 reverse transcriptase.J Biol Chem1990https://conductscience.org/library/papers/1693920PubMed
72,169,648Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein.Science1990https://conductscience.org/library/papers/2169648PubMed
82,173,791Plus-strand origin for human immunodeficiency virus type 1: implications for integration.J Virol1990https://conductscience.org/library/papers/2173791PubMed
91,713,059Human immunodeficiency virus reverse transcriptase ribonuclease H: specificity of tRNA(Lys3)-primer excision.Biochemistry1991https://conductscience.org/library/papers/1713059PubMed
101,718,968A recombinant ribonuclease H domain of HIV-1 reverse transcriptase that is enzymatically active.J Biol Chem1991https://conductscience.org/library/papers/1718968PubMed

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
31,269,675Structural and Functional Aspects of Foamy Virus Protease-Reverse Transcriptase.Viruses2019https://conductscience.org/library/papers/31269675PubMed
24,880,687Structures of HIV-1 RT-RNA/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA/DNA: insights into requirements for RNase H cleavage.Nucleic Acids Res2014https://conductscience.org/library/papers/24880687PubMed
23,382,176Structural analysis of monomeric retroviral reverse transcriptase in complex with an RNA/DNA hybrid.Nucleic Acids Res2013https://conductscience.org/library/papers/23382176PubMed
22,962,864The solution structure of the prototype foamy virus RNase H domain indicates an important role of the basic loop in substrate binding.Retrovirology2012https://conductscience.org/library/papers/22962864PubMed
22,366,278Crystal structures of the reverse transcriptase-associated ribonuclease H domain of xenotropic murine leukemia-virus related virus.J Struct Biol2012https://conductscience.org/library/papers/22366278PubMed
22,325,739Insights into the structure and activity of prototype foamy virus RNase H.Retrovirology2012https://conductscience.org/library/papers/22325739PubMed
20,358,252Retroviral reverse transcriptases.Cell Mol Life Sci2010https://conductscience.org/library/papers/20358252PubMed
20,122,939Multiple nucleotide preferences determine cleavage-site recognition by the HIV-1 and M-MuLV RNases H.J Mol Biol2010https://conductscience.org/library/papers/20122939PubMed
19,228,195Ribonuclease H: properties, substrate specificity and roles in retroviral reverse transcription.FEBS J2009https://conductscience.org/library/papers/19228195PubMed
18,261,820RNase H activity: structure, specificity, and function in reverse transcription.Virus Res2008https://conductscience.org/library/papers/18261820PubMed

1 to 10 of 16

See all 16 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8970988

GET https://conductscience.org/api/papers/v1/8970988/references?page=2